Influence of fluid therapy on the haemostatic system of intensive care patients

Best Practice and Research: Clinical Anaesthesiology

Volumn 23, Issue 2, 2009, Pages 225-236

  Kozek Langenecker, Sibylle A ^a,b  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b Evangelisches Krankenhaus Vienna   (Austria)

Author keywords

albumin; coagulation factors; crystalloid; dextran; fibrin polymerization; fibrinolysis; gelatin; hydroxyethyl starch; hypercoagulability; platelet function; sepsis associated coagulopathy; trauma induced coagulopathy

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; DEXTRAN; FIBRINOGEN; GELATIN; HETASTARCH; HUMAN SERUM ALBUMIN; OXYPOLYGELATIN; RINGER LACTATE SOLUTION; SODIUM CHLORIDE; VON WILLEBRAND FACTOR;

ANAPHYLAXIS; ANTICOAGULATION; BLEEDING TIME; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CLINICAL TRIAL; COLLOID; DRUG EFFICACY; DRUG MEGADOSE; FIBRIN POLYMERIZATION; FIBRINOLYSIS; FLUID RESUSCITATION; FLUID THERAPY; HEMODILUTION; HEMOSTASIS; HUMAN; HYPERCHLOREMIC ACIDOSIS; HYPERCOAGULABILITY; HYPOCOAGULABILITY; INTENSIVE CARE; KIDNEY FAILURE; LIVER FAILURE; NONHUMAN; ONCOTIC PRESSURE; PRIORITY JOURNAL; REVIEW; SEPSIS; THROMBOCYTE AGGREGATION; THROMBOCYTE DISORDER; VON WILLEBRAND DISEASE;

BLOOD COAGULATION DISORDERS; BLOOD PLATELETS; COLLOIDS; FLUID THERAPY; HEMOSTASIS; HETASTARCH; HUMANS; INTENSIVE CARE; THROMBIN;

EID: 66549099243     PISSN: 15216896     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bpa.2008.11.002     Document Type: Review

References (100)

1. Kozek-Langenecker S. Effects of hydroxyethyl starch solutions on hemostasis. Anesthesiology 103 (2005) 654-660
2. Kozek-Langenecker S., and Scharbert G. Effect of hydroxyethyl starches on hemostasis. Transfusion Alternatives in Transfusion Medicine 9 (2007) 173-181
3. Van der Linden P., and Ickx B. The effects of colloid solutions on hemostasis. Canadian Journal of Anaesthesia 53 (2006) S30-S39
4. Stögermüller B., Stark J., Willschke H., et al. The effects of hydroxyethyl starch 200 kD on platelet function. Anesthesia and Analgesia 91 (2000) 823-827
5. Franz A., Bräunlich P., Gamsjäger T., et al. The effects of hydroxyethyl starches of varying molecular weight on platelet function. Anesthesia and Analgesia 92 (2001) 1402-1407
6. Huttner I., Boldt J., Haisch G., et al. Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. British Journal of Anaesthesia 85 (2000) 417-423
7. Omar M., Shouk T., and Khaleq M. Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement. Clinical Biochemistry 32 (1999) 269-274
8. Gamsjäger T., Gustorff B., and Kozek-Langenecker S. The effects of hydroxyethyl starches on intracellular calcium in platelets. Anesthesia and Analgesia 95 (2002) 866-869
9. Deusch E., Gamsjäger T., Kress H., et al. Binding of hydroxyethyl starch molecules to the platelet surface. Anesthesia and Analgesia 97 (2003) 680-683
10. deJonge E., and Levi M. Effects of different plasma substitutes on blood coagulation: a comparative review. Critical Care Medicine 29 (2001) 1261-1267
11. Thaler U., Deusch E., and Kozek-Langenecker S. In vitro effects of various gelatin solutions on platelet function and their comparison to hydroxyethyl starch solutions. Anaesthesia 60 (2005) 554-559
12. deJonge E., Levi M., Berends F., et al. Impaired haemostasis by intravenous administration of a gelatin-based plasma expander in human subjects. Thrombosis and Haemostasis 79 (1998) 286-290
13. Kheirabadi B., Crissey J., Deguzman R., et al. Effects of synthetic versus natural colloid resuscitation on inducing dilutional coagulopathy and increasing hemorrhage in rabbits. The Journal of Trauma 64 (2008) 1218-1228
14. Battle J., F D., Lopez Fernandez M., et al. Effect of dextran on factor VIII/von Willebrand factor structure and function. Thrombosis and Haemostasis 54 (1985) 697-699
15. Mittermayr M., Streif W., Haas T., et al. Haemostatic changes after crystalloid or colloid fluid administration during orthopedic surgery: the role of fibrinogen administration. Anesthesia and Analgesia 105 (2007) 905-917
16. Petroianu G., Maleck W., Koetter K., et al. Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors. Critical Care Medicine 31 (2003) 250-254
17. Entholzer E., Mielke L., Calatzis A., et al. Coagulation effects of a recently developed hydroxyethyl starch (HES 130/0.4) compared to hydroxyethyl starches with higher molecular weight. Acta Anaesthesiologica Scandinavica 44 (2000) 1116-1121
18. Tobias M., Wambold D., Pilla M., et al. Differential effects of serial hemodilution with hydroxyethyl starch, albumin, and 0.9% saline on whole blood coagulation. Journal of Clinical Anesthesia 10 (1998) 366-371
19. Fries D., Innerhofer P., Klingler A., et al. The effects of the combined administration of colloids and lactated Ringer's solution on the coagulation system: an in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesthesia and Analgesia 94 (2002) 1280-1287
20. Nielsen V. Effects of PentaLyte and Voluven hemodilution on plasma coagulation kinetics in the rabbit: role of thrombin-fibrinogen and factor XIII-fibrin polymer interactions. Acta Anaesthesiologica Scandinavica 49 (2005) 1263-1271
21. Strauss R., Pennell B., and Stump D. A randomized controlled trial comparing the hemostatic effects of pentastarch versus hetastarch. Transfusion 42 (2002) 27-36
22. Boldt J., Haisch G., Suttner S., et al. Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. British Journal of Anaesthesia 89 (2002) 722-728
23. Nielsen V. Hemodilution modulates the time of onset and rate of fibrinolysis in human and rabbit plasma. The Journal of Heart and Lung Transplantation 25 (2006) 1344-1352
24. Niemi T., and Kuitunen A. Artificial colloids impair haemostasis. An in vitro study using thromboelastometry coagulation analysis. Acta Anaesthesiologica Scandinavica 49 (2005) 373-378
25. deJonge E., Levi M., Buller R., et al. Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Medicine 27 (2001) 1825-1829
26. Jamnicki M., Bombeli T., Seifert B., et al. Low- and medium-molecular-weight hydroxyethyl starches: comparison of their effect on blood coagulation. Anesthesiology 93 (2000) 1231-1237
27. Kapiotis S., Quehenberger P., Eichler H., et al. Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: comparison with albumin. Critical Care Medicine 22 (1994) 606-612
28. Conroy J., Fishman R., Reeves S., et al. The effects of desmopressin and 6% hydroxyethyl starch on factor VIII: C. Anesthesia and Analgesia 83 (1996) 804-807
29. Treib J., Haass A., Pindur G., et al. All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 36 (1996) 450-455
30. Jungheinrich C., Sauermann W., Bepperling F., et al. Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopedic surgery: a randomised, double-blind study. Drugs in R&D 5 (2004) 1-9
31. Neff T., Doelberg M., Jungheinrich C., et al. Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesthesia and Analgesia 96 (2003) 1453-1459
32. Kasper S., Meinert P., Kampe S., et al. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 99 (2003) 42-47
33. Kuitunen A., Hynynen M., Vahtera E., et al. Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesthesia and Analgesia 98 (2004) 291-297
34. Gallandat-Huet R., Siemons A., Baus D., et al. A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Canadian Journal of Anaesthesia 47 (2000) 1207-1215
35. Langeron O., Doelberg M., Ang E., et al. Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesthesia and Analgesia 92 (2001) 855-862
36. Ellger B., Freyhoff J., van Aken H., et al. High-dose volume replacement using HES 130/0.4 during major surgery. Nederlands Tijdschrift Voor Gerontologie 19 (2006) 63-68
37. Ruttmann T.G., James M.F., and Viljoen J.F. Haemodilution induces a hypercoagulable state. British Journal of Anaesthesia 76 (1996) 412-414
38. ® in rabbits: role of heparin-dependent serpins and factor VIII complex. Anesthesia and Analgesia 95 (2002) 844-850
39. Li L., and Xu X. Effect of acute progressive normovolemic hemodilution with lactated Ringer's, gelatin and hydroxyethyl starch on coagulation and survival rate in rabbits. Beijing Da Xue Xue Bao 40 (2008) 292-300
40. Kretschmer V., Daraktchiev A., Bade S., et al. Does hemodilution enhance coagulability?. Anästhesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS 39 (2004) 751-756
41. Innerhofer P., Fries D., Margreiter J., et al. The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesthesia and Analgesia 95 (2002) 858-865
42. Jamnicki M., Zollinger A., Seifert B., et al. Compromised blood coagulation: an in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesthesia and Analgesia 87 (1998) 989-993
43. von Roten I., Madjdpour C., Frascarolo P., et al. Molar substitution and C2/C6 ratio of hydroxyethyl starch: influence on blood coagulation. British Journal of Anaesthesia 96 (2006) 455-463
44. Madjdpour C., Dettori N., Frascarolo P., et al. Molecular weight of hydroxyethyl starch: is there an effect on blood coagulation and pharmacokinetics?. British Journal of Anaesthesia 94 (2005) 569-576
45. Thyes C., Madjdpour C., Frascarolo P., et al. Effect of high- and low-molecular-weight low-substituted hydroxyethyl starch on blood coagulation during acute normovolemic hemodilution in pigs. Anesthesiology 105 (2006) 1228-1237
46. Strauss R., Stump D., Henriksen R., et al. Effects of hydroxyethyl starch on fibrinogen, fibrin clot formation and fibrinolysis. Transfusion 25 (1985) 230-234
47. Fenger-Eriksen C., Heslop J., Anker-Moller E., et al. Thrombelastographic whole blood clot formation following ex vivo addition of plasma substitutes: improvements of the induced coagulopathy with fibrinogen concentrate. British Journal of Anaesthesia 94 (2005) 324-329
48. Nielsen V. Colloids decrease clot propagation and strength: role of factor XIII-fibrin polymer and thrombin-fibrinogen interactions. Acta Anaesthesiologica Scandinavica 49 (2005) 1163-1171
49. Nielsen V., and Kirklin J. Hydroxyethyl starch enhances argatroban-mediated decrease in clot propagation and strength by diminishing thrombin-fibrinogen interactions. Blood Coagulation & Fibrinolysis 18 (2007) 49-54
50. Jones S., Whitten C., Despotis G., et al. The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: a preliminary survey of hemostatic markers. Anesthesia and Analgesia 96 (2003) 363-368
51. Konrad C., Markl T., Schuepfer G., et al. The effects of in vitro hemodilution with gelatin, hydroxyethyl starch, and lactated Ringer's solution on markers of coagulation: an analysis using Sonoclot™. Anesthesia and Analgesia 88 (1999) 483-488
52. Haas T., Preinreich A., Oswald E., et al. Effects of albumin 5% and artificial colloids on clot formation in small infants. Anaesthesia 62 (2008) 1000-1007
53. Ickx B., and Van der Linden P. Interactions entre les solutes colloides et l'hemostase. Sang Thrombose Vaisseaux 14 (2002) 408-416
54. Mittermayr M., Streif W., Haas T., et al. Effects of colloid and crystalloid solutions on endogenous activation of fibrinolysis and resistance of polymerized fibrin to recombinant tissue plasminogen activator added ex vivo. British Journal of Anaesthesia 100 (2008) 307-314
55. Eriksson M., and Saldeen T. Effect of dextran on plasma tissue plasminogen activator (t-PA) and plasminogen activator inhibitor-1 (PAI-1) during surgery. Acta Anaesthesiologica Scandinavica 39 (1995) 163-166
56. Mohri H. Acquired von Willebrand syndrome: features and management. American Journal of Hematology 81 (2006) 616-623
57. Sorensen B., Fenger-Eriksen C., and Ingerslev J. Recombinant factor VIIa fails to correct coagulopathy induced by haemodilution with colloids. British Journal of Anaesthesia 94 (2005) 862-863
58. Fries D., Krismer A., Klingler A., et al. Effect of fibrinogen on reversal of dilutional coagulopathy: a porcine model. British Journal of Anaesthesia 95 (2005) 172-177
59. Haas T., Fries D., Velik-Salchner C., et al. The in vitro effects of fibrinogen concentrate, factor XIII and fresh frozen plasma on impaired clot formation after 60% dilution. Anesthesia and Analgesia 106 (2008) 1360-1365
60. Lehmann G., Marx G., and Foerster H. Bioequivalence comparison between hydroxyethyl starch 130/0.42/6: 1 and hydroxyethyl starch 130/0.4/9: 1. Journal of Drugs in R&D 8 (2007) 229-240
61. Sander O., Reinhart K., and Meier-Hellmann A. Equivalence of hydroxyethyl starch HES 130/0.4 and HES 200/0.5 for perioperative volume replacement in mayor gynaecological surgery. Acta Anaesthesiologica Scandinavica 47 (2003) 1151-1158
62. Waters J., Gottlieb A., Schoenwald P., et al. Normal saline versus lactated Ringer's solution for intraoperative fluid management in patients undergoing abdominal aortic aneurysma repair: an outcome study. Anesthesia and Analgesia 93 (2001) 817-822
63. Stephens R., and Mythen M. Optimizing intraoperative fluid therapy. Current Opinion in Anaesthesiology 16 (2003) 385-392
64. Wilkes N., Woolf R., Mutch M., et al. The effects of balanced versus saline-based hetastarch and crystalloid solutions on acid-base and electrolyte status and gastric mucosal perfusion in elderly surgical patients. Anesthesia and Analgesia 93 (2001) 811-816
65. Base E., Standl T., Lassnig A., et al. Comparison of 6% HES 130/0.4 in a balanced electrolyte solution versus 6% HES 130/0.4 in saline solution in cardiac surgery. Critical Care 10 (2006) P176
66. Engstrom M., Schott U., Romner B., et al. Acidosis impairs the coagulation: a thromboelastographic study. The Journal of Trauma 61 (2006) 624-628
67. Roche A., James M., E B.-G., et al. A head-to-head comparison of the in vitro coagulation effects of saline-based and balanced electrolyte crystalloid and colloid intravenous fluids. Anesthesia and Analgesia 102 (2006) 1274-1279
68. Boldt J., Wolf M., and Mengistu A. A new plasma-adapted hydroxyethylstarch preparation: in vitro coagulation studies using thrombelastography and whole blood aggregometry. Anesthesia and Analgesia 104 (2007) 425-430
69. Weeks D., Jahr J., Lim J., et al. Does hextend impair coagulation compared to 6% hetastarch? An ex vivo thrombelastography study. American Journal of Therapeutics 15 (2008) 225-230
70. Scharbert G., and Kozek-Langenecker S. Limitations of in vitro models. Anesthesia and Analgesia 105 (2007) 885
71. Deusch E., Thaler U., and Kozek-Langenecker S. The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesthesia and Analgesia 99 (2004) 665-668
72. Gan T.J., Bennett-Guerrero E., Phillips-Bute B., et al. Hextend, a physiologically balanced plasma expander for large volume use in major surgery: a randomized phase III clinical trial. Anesthesia and Analgesia 88 (1999) 992-998
73. Boldt J., Schöllhorn T., Münchbach J., et al. A total balanced volume replacement strategy using a new balanced hydroxyethyl starch preparation (6% HES 130/0.42) in patients undergoing major abdominal surgery. European Journal of Anaesthesiology 24 (2007) 267-275
74. Kulla M., Weidhase R., and Lampl L. Hydroxyethylstärke 6% 130/0,42 in Ringerazetat als Komponente eines balancierten Volumenersatzes in der Abdominalchirurgie. Anästhesiologie und Intensivmedizin 49 (2008) 7-18
75. Wilkes M., Navickis R., and Sibbald W. Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: a meta-analysis of postoperative bleeding. Annals of Thoracic Surgery 72 (2001) 527-537
76. Haisch G., Boldt J., Krebs C., et al. The influence of intravascular volume therapy with a new hydroxyethyl starch preparation (6% HES 130/0.4) on coagulation in patients undergoing major abdominal surgery. Anesthesia and Analgesia 92 (2001) 565-571
77. Boldt J., Knothe C., Zickmann B., et al. Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesthesia and Analgesia 76 (1993) 1185-1190
78. Gandhi S., Weiskopf R., Jungheinrich C., et al. Volume replacement therapy during major orthopedic surgery using Voluven (hydroxyethyl starch 130/0.4) or hetastarch. Anesthesiology 106 (2007) 1120-1127
79. Kozek-Langenecker S, Jungheinrich C, Sauermann W, et al. Hydroxyethyl starch 130/0.4 (6%): effects on blood loss and use of blood products in major surgery - a pooled analysis of randomized clinical trials. Anesthesia and Analgesia 2008;107:382-390.
80. Cheng D., Belisle S., Giffin M., et al. Colloids for perioperative plasma volume expansion: systematic review with meta-analysis of controlled trials. Transfusion Alternatives in Transfusion Medicine 9 (2007) 3 (abstract)
81. Haas T., Fries D., Holz C., et al. Less impairment of hemostasis and reduced blood loss in pigs after resuscitation from hemorrhagic shock using the small-volume concept with hypertonic saline/hydroxyethyl starch as compared to administration of 4% gelatin or 6% hydroxyethyl starch solution. Anesthesia and Analgesia 106 (2008) 1078-1086
82. Standl T., Burmeister M., Schroeder F., et al. Hydroxyethyl starch (HES) 130/0.4 provides larger and faster increases in tissue oxygen tension in comparison with prehemodilution values than HES 70/0.5 or HES 200/0.5 in volunteers undergoing acute normovolemic hemodilution. Anesthesia and Analgesia 96 (2003) 936-943
83. Tabuchi N., de Haan J., Gallandat-Huet R., et al. Gelatin use impairs platelet adhesion during cardiac surgery. Thrombosis and Haemostasis 74 (1995) 1447-1451
84. Mahla E., Lang T., Vincenzi M., et al. Thrombelastography for monitoring prolonged hypercoagulability after major abdominal surgery. Anesthesia and Analgesia 92 (2001) 572-577
85. McCrath D.J., Cerboni E., Frumento R.J., et al. Thromboelastography maximum amplitude predicts postoperative thrombotic complications including myocardial infarction. Anesthesia and Analgesia 100 (2005) 1576-1583
86. Collins P., Macchiavello L., Lewis S., et al. Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. British Journal of Haematology 135 (2006) 220-227
87. Wang L., Bastarache J., and Ware L. The coagulation cascade in sepsis. Current Pharmaceutical Design 14 (2008) 1860-1869
88. Dieterich H., Weissmüller T., Rosenberger P., et al. Effect of hydroxyethyl starch on vascular leak syndrome and neutrophil accumulation during hypoxia. Critical Care Medicine 34 (2004) 1775-1782
89. Lang K., Suttner S., Boldt J., et al. Volume replacement with HES 130/0.4 may reduce the inflammatory response in patients undergoing major abdominal surgery. Canadian Journal of Anaesthesia 50 (2003) 1009-1016
90. Volta A., Alvis V., Campi M., et al. Influence of different strategies of volume replacement on the activity of matrix metalloproteinase: an in vitro and in vivo study. Anesthesiology 106 (2007) 85-91
91. Meyer P., Pernet P., Hejblum B., et al. Haemodilution induced by hydroxyethyl starches 130/0.4 is similar in septic and non-septic patients. Acta Anaesthesiologica Scandinavica 52 (2008) 229-235
92. Hardy J.F., de Moerloose P., and Samama C.M. Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Canadian Journal of Anaesthesia 53 (2006) S40-S58
93. Kozek-Langenecker S. Management of massive operative blood loss. Minerva Anestesiologica 73 (2007) 401-415
94. Watters J., Tieu B., Differding J., et al. A single bolus of 3% hypertonic saline with 6% dextran provides optimal initial resuscitation after uncontrolled hemorrhagic shock. The Journal of Trauma 61 (2006) 75-81
95. Wiedermann I., Scharbert G., Schöchl H., et al. Hydroxyethyl starch in hypertonic saline and platelet function. Anesthesiology 107 (2007) A549
96. Brummel-Ziedins K., Whelihan M., Ziedins E., et al. The resuscitation fluid you choose may potentiate bleeding. The Journal of Trauma 61 (2006) 1350-1358
97. Singh N., Singh S., Kaur L., et al. Morphological, thermal and rheological properties of starches from different botanical sources. Food Chemistry 81 (2003) 219-231
98. Kwan I., Bunn F., and Robert F. Timing and volume of fluid administration for patients with bleeding. Cochrane Database of Systematic Reviews 3 (2003) CD002245
99. Perel P., and Roberts I. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database of Systematic Reviews 4 (2008) CD000567
100. Kozek-Langenecker S., and Scharbert G. Which hemostatic changes determine clinical outcome?. Anesthesia and Analgesia 106 (2008) 1588